Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α- pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 796, Issue 2, 2003, Pages 253-266

  Springer, Dietmar ^a   Fritschi, Giselher ^b   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Hessisches Landeskriminalamt   (Germany)

Author keywords

4 Methyl pyrrolidinopropiophenone; Pyrrolidinopropiophenone

Indexed keywords

DEHYDROGENATION; DRUG PRODUCTS; EXTRACTION; HYDROXYLATION; MASS SPECTROMETRY; TOXIC MATERIALS;

DEALKYLATION;

GAS CHROMATOGRAPHY;

4' METHYL ALPHA PYRROLIDINOPROPIOPHENONE; ALPHA PYRROLIDINOPROPIOPHENONE; PROPIOPHENONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HYDROGENATION; HYDROXYLATION; MALE; MASS SPECTROMETRY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID PHASE EXTRACTION; TOXICOKINETICS; URINALYSIS;

EID: 0142165136     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.07.008     Document Type: Article

References (37)

1. Roesner P., Junge T., Fritschi G., Klein B., Thielert K., Kozlowski M. Toxichem. Krimtech. 66:1999;81.
2. D. Springer, F.T. Peters, G. Fritschi, H.H. Maurer, in: F. Pragst, R. Aderjan (Eds.), Proceedings of the XIIth GTFCh Symposium in Mosbach, Helm-Verlag, Heppenheim, Germany, 2001, p. 156.
3. D. Springer, F.T. Peters, G. Fritschi, H.H. Maurer, in: M. Balikova, E. Navakova (Eds.), Proceedings of the 39th International TIAFT Meeting in Prague, 2001, Charles University, Prague, 2002, p. 122.
4. Springer D., Peters F.T., Fritschi G., Maurer H.H. J. Chromatogr. B. 773:2002;25.
5. Springer D., Peters F.T., Fritschi G., Maurer H.H. J. Chromatogr. B. 789:2003;79.
6. Springer D., Fritschi G., Maurer H.H. J. Chromatogr. B. 793:2003;331.
7. Springer D., Fritschi G., Maurer H.H. J. Chromatogr. B. 793:2003;377.
8. Martinez M., Mercado O., Santamaria A., Galvan S., Vazquez M., Bucio V., Hall C., Hernandez R., Hurtazo A., Pego E., Rodriguez F., Salvatierra R., Sosa A., Rios C. Proc. West. Pharmacol. Soc. 41:1998;125.
9. Bryant S.G., Guernsey B.G., Ingrim N.B. Clin. Pharm. 2:1983;525.
10. Kalix P., Glennon R.A. Biochem. Pharmacol. 35:1986;3015.
11. Glennon R.A., Yousif M., Naiman N., Kalix P. Pharmacol. Biochem. Behav. 26:1987;547.
12. H.H. Maurer, in: K. Pfleger, H.H. Maurer, A. Weber (Eds.), Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 4, Wiley-VCH, Weinheim, 2000, p. 3.
13. McKay A.F., Ott W.L., Taylor G.W., Buchanan M.N., Crooker J.F. Canadian J. Res. 28(B):1950;683.
14. T. Kraemer, A.A. Weber, H.H. Maurer, in: F. Pragst (Ed.), Helm-Verlag, Heppenheim, ISBN 3-923032-10-2, 1997, p. 200.
15. Maurer H.H., Bickeboeller-Friedrich J., Kraemer T., Peters F.T. Toxicol. Lett. 112:2000;133.
16. Maurer H.H. Spectros. Eur. 6:1994;21.
17. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, 4th Revision, Agilent Technologies, Palo Alto, CA, 2004, in preparation.
18. Staack R.F., Fritschi G., Maurer H.H. J. Chromatogr. B. 773:2002;35.
19. Bickeboeller-Friedrich J., Maurer H.H. Ther. Drug Monit. 23:2001;61.
20. Maurer H.H. Comb. Chem. High Throughput Screen. 3:2000;461.
21. Maurer H.H., Bickeboeller-Friedrich J. J. Anal. Toxicol. 24:2000;340.
22. Pokrajac M., Miljkovic B., Misailovic B. Rapid. Commun. Mass. Spectrom. 5:1991;59.
23. Brenneisen R., Geisshusler S. Pharm. Acta Helv. 60:1985;290.
24. Kraemer T., Bickeboeller-Friedrich J., Maurer H.H. Drug Metab. Dispos. 28:2000;339.
25. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 4, Wiley-VCH, Weinheim, 2000.
26. F.W. McLafferty, F. Turecek, Interpretation of Mass Spectra, University Science Books, Mill Valley, CA, 1993.
27. R.M. Smith, K.L. Busch, Understanding Mass Spectra - A Basic Approach, Wiley, New York, NY, 1999.
28. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, VCH Publisher, Weinheim, 1992.
29. Maurer H.H., Bickeboeller-Friedrich J. Ther. Drug Monit. 19:1997;583.
30. Kraemer T., Maurer H.H. Ther. Drug Monit. 24:2002;277.
31. Beckett A.H., Stanojcic M. J. Pharm. Pharmacol. 39:1987;409.
32. Markantonis S.L., Kyroudis A., Beckett A.H. Biochem. Pharmacol. 35:1986;529.
33. K. Schwetlick, Organikum, Wiley-VCH, Weinheim, 2001.
34. K. Pfleger, H.H. Maurer, A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 5, Wiley-VCH, Weinheim, 2004, in preparation.
35. Kovats E. Helv. Chim. Acta. 41:1958;1915.
36. R.A. de-Zeeuw, J.P. Franke, H.H. Maurer, K. Pfleger, Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and Their Metabolites, Report of the DFG Commission for Clinical Toxicological Analysis, Special Issue of the TIAFT Bulletin, VCH publishers, Weinheim, New York, Basle, 1992.
37. DFG Senatskommission für Klinisch-Toxikologische Analytik, J. Clin. Chem. Clin. Biochem. 20 (1982) 699.